Clinical Trial 44153

Winter Haven, FL 33880


Summary:

This study will be an open-label, 12 month study to assess PRN usage of STS101 (DHE nasal powder) for migraine treatment.Study participants will be able to use up to 2 doses of STS101 to treat a single migraine attack within 24 hours and can use up to 12 doses of STS101 per month for 12 months.


Qualified Participants Must:

• Between 18-65 years of age
• Have had migraine onset before 50 years of age
• History of 4-12 migraine attacks per month on average
• Have to be tobacco free for at least 1 year prior to screening


Qualified Participants May Receive:

- Compensation for time and travel expenses

- Laboratory testing such as blood work and an EKG

- Physical performed by a board certified physician


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.